Patient Fights Insurance for Lifesaving Care

Patients across the United States continue to face significant challenges with health insurance prior authorization processes. Sheldon Ekirch, from Henrico, Virginia, finally secured coverage for intravenous immunoglobulin (IVIG) after a two-year battle with Anthem, which had repeatedly denied the costly treatment. Her parents had spent approximately $90,000 out-of-pocket while awaiting approval.

Despite pledges made in June by health insurance leaders to simplify prior authorization, many companies have failed to provide specific details about services no longer requiring preapproval. Physician groups and patient advocates express pessimism about voluntary changes, suggesting that insurers prioritize financial interests over patient well-being.

While some insurers like Aetna, Humana, and UnitedHealthcare have cited specific changes such as bundling authorizations or removing them for certain diagnostic services, health care insiders remain skeptical. The American Medical Association noted that past promises of reform have not led to meaningful improvements, with the process remaining costly, inefficient, and hazardous for patients.

Payton Herres, a 25-year-old from Dayton, Ohio, experienced Anthem denying coverage for a vital antirejection medication after more than a decade of receiving it. Similarly, Anna Hocum, of Milwaukee, faced repeated denials for treatment of a rare genetic condition, relying on crowdfunding to cover costs while awaiting insurer reversals.

Ekirch's authorization for IVIG is valid for one year from September 25, 2025, but her upcoming transition to a new insurance plan in April creates new anxieties about facing prior authorization battles again. The ongoing struggles highlight the systemic issues patients face in accessing necessary medical care.